ROS-triggerable dual nanocoated probiotics for inflammatory bowel disease treatment

Inflammatory bowel disease (IBD), an immune-mediated chronic gastrointestinal disease, is difficult to treat because its specific pathogenic mechanisms are currently unclear, and its recurrence rate is high. Probiotic therapies have been used to treat IBD; however, challenges, including poor digesti...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Guangze Sang, Sizhen Wang, Qiwei Tai, Yunchang Zhang, Xufang Wang, Baoling Yan, Weiwei Jiang, Zhendong Chen, Linhong Sun, Jiao Zhou, Xiaoxian Wu, Zi Ye, Feng Yang, Jun Luo, Beibei Guo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2026-12-01
Serie:	Drug Delivery
Soggetti:	Inflammatory bowel disease ulcerative colitis probiotics catechin Escherichia coli Nissle 1917
Accesso online:	https://www.tandfonline.com/doi/10.1080/10717544.2026.2630460
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!